A U of A Cancer Center team led by the Division of Hematology & Oncology’s Drs. Steffan Nawrocki and Jennifer Carew identified a novel biomarker to predict which patients with clear cell renal cell carcinoma may best benefit from a targeted combination therapy involving autophagy inhibition.

This week, 120 students will take part in the annual White Coat Ceremony that serves as a welcome for the Class of 2029, presenting them with their first physician’s white coats.

Researchers will take a precision medicine approach to treating obstructive sleep apnea in people with Down syndrome.

Researchers found a two-way relationship between some vitamin and mineral deficiencies and chronic pain, which could lead to personalized treatments.

Physiology department head advocates for holistic, innovative approach to ancient discipline.

Graduates of the Bachelor of Science in Medical Device Development and Application program will be well equipped for careers in the biotechnology field.

Medical students who want to specialize in primary care can take advantage of an accelerated pathway to residency training.

The Division of Infectious Diseases and Valley Fever Center for Excellence physician-scientist is on the front line in the fight for her patients and to bring increased attention to the fungal disease.

A new paper published in Nature provides insights into why men with loss of Y have increased cancer risks and poorer outcomes.